We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Quincy Bioscience Begins Recruitment for Migraine Study

News   Feb 13, 2012

 
Quincy Bioscience Begins Recruitment for Migraine Study
 
 
Advertisement
 

RELATED ARTICLES

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

News

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

READ MORE

Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2

News

Two peptides once combined, work together to penetrate cells' membranes in order to dampen an acute inflammatory response. In this first ex vivo study, the peptide reduced collagen degradation. The researchers say the peptide could alleviate some of the worst damage caused by acute inflammatory responses.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE